Optimization of Evans blue quantitation in limited rat tissue samples

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Wang, Hwai Lee ^a   Lai, Ted Weita ^a,b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COLORING AGENT; EVANS BLUE;

ANIMAL; BLOOD BRAIN BARRIER; BRAIN MAPPING; CAPILLARY PERMEABILITY; CHEMISTRY; DIAGNOSTIC USE; HUMAN; PHYSIOLOGY; RAT; SPECTROFLUOROMETRY; ULTRASTRUCTURE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN MAPPING; CAPILLARY PERMEABILITY; COLORING AGENTS; EVANS BLUE; HUMANS; RATS; SPECTROMETRY, FLUORESCENCE;

EID: 84942871468     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06588     Document Type: Article

References (35)

1. Evans, H. M. & Schulemann, W. The Action of Vital Stains Belonging to the Benzidine Group. Science 39, 443-454, doi:10.1126/science.39.1004.443 (1914).
2. Keith, N. M., Rowntree, L. G. & Geraghty, J. T. A method for the determination of plasma and blood volume. Arch Intern Med (Chic) XVI, 547-576 (1915).
3. Robertson, O. H. & Bock, A. V. Blood Volume in Wounded Soldiers: I. Blood Volume and Related Blood Changes after Hemorrhage. J Exp Med 29, 139-153 (1919).
4. Dawson, A. B., Evans, H. M. & Whipple, G. H. BLOOD VOLUME STUDIES III. Behavior of Large Series of Dyes Introduced into the Circulating Blood. Am J Physiol 51, 232-256 (1920).
5. Rawson, R. A. The binding of T-1824 and structurally related diazo dyes by the plasma proteins. Am J Physiol 138, 708-717 (1943).
6. Gregersen, M. I., Gibson, J. J. & Stead, E. A. Plasma volume determination with dyes: errors in colorimetry; use of the blue dye T-1824. Am J Physiol 113, 54-55 (1935).
7. Yen, L. F., and Wei, V. C., Kuo, E. Y. & Lai, T. W. Distinct patterns of cerebral extravasation by evans blue and sodium fluorescein in rats. PLoS One 8, e68595, doi:10.1371/journal.pone.0068595 (2013).
8. Crooke, A. C. & Morris, C. J. The determination of plasma volume by the Evans blue method. J Physiol 101, 217-223 (1942).
9. Bowler, R. G., Crooke, A. C. & Morris, C. J. The effect of morphine and hyoscine on dye concentration curves in plasma volume determination. J Physiol 103, 137-141 (1944).
10. Crooke, A. C., Morris, C. J. & Bowler, R. G. General Anaesthesia in Shock. Br Med J 2, 683-686 (1944).
11. Gregersen, M. I. & Rawson, R. A. The disappearance of T-1824 and structurally related dyes from the blood stream. Am J Physiol 138, 698-707 (1943).
12. Rossner, W. & Tempel, K. [Quantitative determination of the permeability of the so-called blood-brain barrier of Evans blue (T 1824)]. Med Pharmacol Exp Int J Exp Med 14, 169-182 (1966).
13. Theron, P. H. & Wilson, W. C. Blood changes in peritonitis. Lancet 1, 172-178 (1949).
14. Dacie, J. V. & Homer, G. F. Blood-loss in battle casualties; use of transfusion fluids. Lancet 1, 371-377 (1946).
15. Crooke, A. C., Morris, C. J. & Bowler, R. G. Plasma Volume in Traumatic Shock. Br Med J 2, 521-522 (1944).
16. Sutherland, T. M. & Young, D. A. Increased permeability of the capillaries of the rat heart to plasma albumin with asphyxiation and with perfusion. J Physiol 183, 112-122 (1966).
17. Steinwall, O. & Klatzo, I. Selective vulnerability of the blood-brain barrier in chemically induced lesions. J Neuropathol Exp Neurol 25, 542-559 (1966).
18. Saria, A. & Lundberg, J. M. Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J Neurosci Methods 8, 41-49 (1983).
19. Clasen, R. A., Pandolfi, S. & Hass, G. M. Vital staining, serum albumin and the blood-brain barrier. J Neuropathol Exp Neurol 29, 266-284 (1970).
20. Chen, K. B. et al. Increase in Evans blue dye extravasation into the brain in the late developmental stage. Neuroreport 23, 699-701, doi:10.1097/WNR.0b013e3283556dcc (2012).
21. Morris, C. J. The determination of plasma volume by the Evans blue method: the analysis of haemolysed plasma. J Physiol 102, 441-445 (1944).
22. Allen, T. H., Ochoa, M., Roth, R. F. & Gregersen, M. I. Spectral absorption of T-1824 in plasma of various species and recovery of the dye by extraction. Am J Physiol 175, 243-246 (1953).
23. Grimbleby, F. H. & Ntailianas, H. A. Binding of trichloroacetic acid by protein. Nature 189, 835-836 (1961).
24. Ay, I., Francis, J. W. & Brown, R. H., Jr. VEGF increases blood-brain barrier permeability to Evans blue dye and tetanus toxin fragment C but not adeno-associated virus in ALS mice. Brain Res 1234, 198-205, doi:10.1016/j.brainres.2008.07.121 (2008).
25. Belayev, L., Busto, R., Zhao, W. & Ginsberg, M. D. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res 739, 88-96 (1996).
26. Wang, Z., Leng, Y., Tsai, L. K., Leeds, P. & Chuang, D. M. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab 31, 52-57, doi:10.1038/jcbfm.2010.195 (2011).
27. Altay, O. et al. Isoflurane attenuates blood-brain barrier disruption in ipsilateral hemisphere after subarachnoid hemorrhage in mice. Stroke 43, 2513-2516, doi:10.1161/STROKEAHA.112.661728 (2012).
28. Jackman, K. et al. Progranulin deficiency promotes post-ischemic blood-brain barrier disruption. J Neurosci 33, 19579-19589, doi:10.1523/JNEUROSCI.4318-13.2013 (2013).
29. Yan, J., Zhou, B., Taheri, S. & Shi, H. Differential effects of HIF-1 inhibition by YC-1 on the overall outcome and blood-brain barrier damage in a rat model of ischemic stroke. PLoS One 6, e27798, doi:10.1371/journal.pone.0027798 (2011).
30. Lee, J. Y., and Kim, H. S., Choi, H. Y., Oh, T. H. & Yune, T. Y. Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood-spinal cord barrier after spinal cord injury. Brain 135, 2375-2389, doi:10.1093/brain/aws171 (2012).
31. Hasegawa, Y., Suzuki, H., Altay, O., Chen, H. & Zhang, J. H. Treatment with sodium orthovanadate reduces blood-brain barrier disruption via phosphatase and tensin homolog deleted on chromosome 10 (PTEN) phosphorylation in experimentalsubarachnoid hemorrhage. J Neurosci Res 90, 691-697, doi:10.1002/jnr.22801 (2012).
32. Uyama, O. et al. Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab 8, 282-284, doi:10.1038/jcbfm.1988.59 (1988).
33. Chen, K. B. et al. Intravenous mannitol does not increase blood-brain barrier permeability to inert dyes in the adult rat forebrain. Neuroreport 24, 303-307, doi:10.1097/WNR.0b013e32835f8acb (2013).
34. Roberts, W. G. & Palade, G. E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108 (Pt 6), 2369-2379 (1995).
35. Lawrence, A. C. & Walters, G. The extraction of Evans blue (T1824) from plasma and the measurement of plasma volume. J Clin Pathol 12, 123-127 (1959).